Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL7811971 | 0.96 | CHRM2 (0.61) | CHRM2CHRM1 | |
| SCHEMBL7810578 | 0.93 | CHRM2 (0.64) | CHRM2CHRM1 | |
| Oxalic Acid SCHEMBL7819179 | 0.91 | CHRM2 (0.58) | CHRM2CHRM1 | |
| SCHEMBL7818477 | 0.89 | CHRM2 (0.58) | CHRM2CHRM1 | |
| SCHEMBL8196540 | 0.87 | CHRM1 (0.60) | CHRM2CHRM1 | |
| SCHEMBL7989374 | 0.85 | CHRM1 (0.56) | CHRM2CHRM1 | |
| SCHEMBL7810793 | 0.85 | CHRM1 (0.56) | CHRM2CHRM1 | |
| SCHEMBL9544481 | 0.85 | CHRM1 (0.58) | CHRM2CHRM1 | |
| Oxalic Acid SCHEMBL7953188 | 0.83 | CHRM1 (0.54) | CHRM2CHRM1 | |
| Oxalic Acid SCHEMBL7810636 | 0.83 | CHRM1 (0.54) | CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6271229-B1 | ADMINISTERING A 1,2,5-OXADIAZOLE COMPOUND OR 1,2,5-THIADIAZOLE COMPOUND | NOVO NORDISK A/S (DK) | 2001-08-07 | — | — | US | claimed |
| EP-0714394-B1 | ANTIPSYCHOTIC METHOD WITH THIADIAZOLE AND OXADIAZOLE DERIVATIVES | NOVO NORDISK AS (DK) | 2001-06-20 | — | — | EP | claimed |
| EP-0544779-B1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK AS (DK) | 1998-12-02 | — | — | EP | claimed |
| EP-0873124-A1 | A METHOD OF TREATING HYPERCHOLESTEROLEMIA AND RELATED DISORDERS | NOVO NORDISK A/S (DK) | 1998-10-28 | — | — | EP | claimed |
| EP-0866702-A1 | METHOD FOR TREATING PAIN | ELI LILLY AND COMPANY (US) | 1998-09-30 | — | — | EP | claimed |
| WO-1997020556-A9 | METHOD FOR TREATING PAIN | — | 1997-10-02 | — | — | WO | claimed |
| EP-0790995-A1 | A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS | NOVO NORDISK A/S (DK) | 1997-08-27 | — | — | EP | claimed |
| WO-1997025043-A1 | A METHOD OF TREATING HYPERCHOLESTEROLEMIA AND RELATED DISORDERS | NOVO NORDISK A/S (DK) | 1997-07-17 | — | — | WO | claimed |
| WO-1997020556-A1 | METHOD FOR TREATING PAIN | ELI LILLY AND COMPANY (US) | 1997-06-12 | — | — | WO | claimed |
| US-5574043-A | ALZHEIMERS, GLAUCOMA, ANALGESIC | NOVO NORDISK A/S (DK) | 1996-11-12 | — | — | US | claimed |
| EP-0735869-A1 | A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS | NOVO NORDISK A/S (DK) | 1996-10-09 | — | — | EP | claimed |
| WO-1996014316-A1 | A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS | NOVO NORDISK A/S (DK) | 1996-05-17 | — | — | WO | claimed |
| EP-0687266-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1995-12-20 | — | — | EP | claimed |
| WO-1995017180-A1 | A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS | NOVO NORDISK A/S (DK) | 1995-06-29 | — | — | WO | claimed |
| WO-1994020496-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1994-09-15 | — | — | WO | claimed |
| EP-0544779-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1993-06-09 | — | — | EP | claimed |
| WO-1992003433-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1992-03-05 | — | — | WO | claimed |
| CN-1292796-A | METH1 and METH2 polynucleotides and polypeptides | BETH ISRAEL DICKNY MEDICAL CT (US) | 2001-04-25 | — | — | CN | disclosed |
| EP-0709093-A2 | Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound | ELI LILLY AND COMPANY (US) | 1996-05-01 | — | — | EP | disclosed |
| US-5484794-A | THIA- OR OXA-DIAZOLE COMPOUNDS | ELI LILLY AND COMPANY (US) | 1996-01-16 | — | — | US | disclosed |